Literature DB >> 23587237

Mechanisms and dynamics of heterochromatin formation during mammalian development: closed paths and open questions.

Anas Fadloun1, André Eid, Maria-Elena Torres-Padilla.   

Abstract

Early embryonic development in mammals is characterized by major changes in the components of the chromatin and its remodeling. The embryonic chromatin and the nuclear organization in the mouse preimplantation embryo display particular features that are dramatically different from somatic cells. These include the highly specific organization of the pericentromeric heterochromatin within the nucleus and the suggested lack of conventional heterochromatin. We postulate that the plasticity of the cells in the early embryo relies on the distinctive heterochromatin features that prevail during early embryogenesis. Here, we review some of these features and discuss recent findings on the mechanisms driving heterochromatin formation after fertilization, in particular, the emerging role of RNA as a regulator of heterochromatic loci also in mammals. Finally, we believe that there are at least three major avenues that should be addressed in the coming years: (i) Is heterochromatin a driving force in development? (ii) Does it have a role in lineage allocation? (iii) How can heterochromatin "regulate" epigenetic reprogramming?
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587237     DOI: 10.1016/B978-0-12-416027-9.00001-2

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  19 in total

1.  Suv39h1 links the SUMO pathway to constitutive heterochromatin.

Authors:  Christèle Maison; Jean-Pierre Quivy; Geneviève Almouzni
Journal:  Mol Cell Oncol       Date:  2016-08-26

Review 2.  Role of H3K9me3 heterochromatin in cell identity establishment and maintenance.

Authors:  Dario Nicetto; Kenneth S Zaret
Journal:  Curr Opin Genet Dev       Date:  2019-05-16       Impact factor: 5.578

Review 3.  Nuclear metabolism and the regulation of the epigenome.

Authors:  Ruben Boon; Giorgia G Silveira; Raul Mostoslavsky
Journal:  Nat Metab       Date:  2020-10-12

Review 4.  Nucleolus and rRNA Gene Chromatin in Early Embryo Development.

Authors:  Jelena Kresoja-Rakic; Raffaella Santoro
Journal:  Trends Genet       Date:  2019-07-18       Impact factor: 11.639

Review 5.  Cancer: pathological nuclear reprogramming?

Authors:  Colin R Goding; Duanqing Pei; Xin Lu
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

Review 6.  H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes.

Authors:  Justin S Becker; Dario Nicetto; Kenneth S Zaret
Journal:  Trends Genet       Date:  2015-12-08       Impact factor: 11.639

7.  Heterochromatin establishment at pericentromeres depends on nuclear position.

Authors:  Joanna W Jachowicz; Angèle Santenard; Ambre Bender; Julius Muller; Maria-Elena Torres-Padilla
Journal:  Genes Dev       Date:  2013-11-15       Impact factor: 11.361

8.  Paternal heterochromatin formation in human embryos is H3K9/HP1 directed and primed by sperm-derived histone modifications.

Authors:  Christine van de Werken; Godfried W van der Heijden; Cindy Eleveld; Miriam Teeuwssen; Mareike Albert; Willy M Baarends; Joop S E Laven; Antoine H F M Peters; Esther B Baart
Journal:  Nat Commun       Date:  2014-12-18       Impact factor: 14.919

9.  TALE-light imaging reveals maternally guided, H3K9me2/3-independent emergence of functional heterochromatin in Drosophila embryos.

Authors:  Kai Yuan; Patrick H O'Farrell
Journal:  Genes Dev       Date:  2016-02-25       Impact factor: 11.361

10.  Genome-wide bisulfite sequencing in zygotes identifies demethylation targets and maps the contribution of TET3 oxidation.

Authors:  Julian R Peat; Wendy Dean; Stephen J Clark; Felix Krueger; Sébastien A Smallwood; Gabriella Ficz; Jong Kyoung Kim; John C Marioni; Timothy A Hore; Wolf Reik
Journal:  Cell Rep       Date:  2014-12-12       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.